India's generic pharmaceutical market has grown steadily as patients and institutions look for effective treatment without the cost burden of branded alternatives.
What's driving demand
- Rising out-of-pocket healthcare spending among middle-income households
- Government procurement programs prioritizing generic formulations
- Increased awareness of bioequivalence between generic and branded drugs
Where this leaves manufacturers
Companies with strong quality certifications and consistent supply chains — like DGQA-approved vendors — are positioned to meet this demand reliably, both for retail and institutional buyers.